Bella North

Regulatory and Privacy

• Advising a global technology provider on entry into the optical manufacturing and ophthalmology services market, including regulatory requirements for remote consultations, clinical oversight, data handling and patient-facing digital health tools.
• Advising health services companies on telemedicine and remote health services, including cross-border teleradiology, teleophthalmology and teledentistry.
• Advising multiple health services and life sciences companies on internal and external investigations on compliance, regulatory and governance matters.
• Advising various global pharmaceutical clients on the regulation and set up of clinical trial arrangements with UK and international contract research organizations (CROs) and contract drug manufacturing organizations (CDMOs).
• Advising multiple medical device companies, on medical device regulatory, collaboration and licensing arrangements, including software as a medical device and digital health tools including patient monitoring and drug dispensing, cardiac monitoring, and behavioral care solutions.
• Advising multiple diagnostics companies on regulatory and commercialization matters for in vitro diagnostics, genetic and molecular testing and direct to consumer testing services.
• Advising multiple health and life sciences companies on data privacy and GDPR, particularly with respect to research, data collaborations, re-use and sharing of health data.

Transactions

• Advised Sycamore Partners, a leading New York-based private equity firm, as UK healthcare regulatory counsel on its acquisition of Walgreens Boots Alliance, Inc. The total transaction is valued at up to $23.7 billion.
• Advised Groupe Bruxelle Lambert, an established European investment company on its investment in Rayner, a leading UK-headquartered global ophthalmic medical device and pharmaceutical company.
• Advised Bridgepoint and the Practice Plus Group on the sale of its hospitals division to Indian healthcare group, Narayana Health.
• Represented Northwestern Memorial Healthcare (Northwestern) a leading U.S. based academic healthcare organization, in its partnership with The London Clinic Limited (TLC), the UK’s largest independent charitable hospital.
• Advising Centene Corporation on its acquisition of Circle Health and subsequent acquisition of BMI Hospitals.
• Advising Best Buy on its acquisition of Current Health digital health and remote monitoring system.
• Advising BehaVR on its acquisition of a digital health and software as a medical device behavioral health therapeutics business operating in the UK and US.
• Advising on the acquisition of a health services and temporary health staffing platform in the UK.
• Advised PharmaLex Group and Auctus Capital on the acquisition of Phlexglobal, a leading technology and services organization for clinical and regulatory compliance solutions, from Vitruvian Partners and subsequent acquisitions including of pharma services technology and related services.
• Advised Vesey Street Capital Partners, a New York-based healthcare services private equity firm, on the acquisition of Inceptua Group, a provider of clinical trial supplies and related services.
• Advised an affiliate of H.I.G. Capital, LLC, on its acquisition of Celerion Holdings Inc., a leading full-service provider of outsourced clinical research services to the pharmaceutical industry.
• Advised Cordis, in its in its acquisition of MedAlliance, a Swiss based company at the forefront of transformative drug-eluting balloons.
• Advising Wellspring Capital Management LLC, in connection with its acquisition of Caring Brands International, Inc. (CBI), the leading franchisor of home healthcare services under three global brands: US-based Interim HealthCare, UK-based Bluebird Care and Australia-based Just Better Care.
• Advised Inverness Graham on life sciences regulatory matters relating to the acquisition of Innovia, global manufacturer of branded single-use surgical products and sterile processing systems servicing ENT, Ophthalmic, Gynecological, and Aesthetic end-markets.

• Legal 500 UK, Recommended, 2025-2026
• Chambers UK, Healthcare: Regulatory, 2025-2026
• Pro Bono Recognition List of England and Wales, 2026